Check the background of this firm on FINRA's BrokerCheck.

Leigh Baldwin & Co.

112 Albany Street, Cazenovia, NY 13035 | Phone: (315) 655-2964 Toll Free: 1-800-659-8044

Check the background of this firm on FINRA's BrokerCheck.

Diamonds and Dogs

3/26/13

Reeds Inc. (REED)

Reeds lost its fizz today down, 6.38% at $4.26. The non-alcoholic beverage company saw its shares go flat after releasing its 2012 full year earnings. Reeds showed some improvement with revenues increasing 20% to $30 million. However, the company was still unable to turn a profit and ultimately announced a net loss of $524,000 for the year. Reeds CFO James Linesch said, "Our fourth quarter losses were primarily due to continued production challenges on our kombucha, resulting in higher unallocated plant costs, and to lighter than expected private label revenues from one customer." Reeds has fallen from its 52-week high of $8.82.

Bovie Medical Corp. (BVX)

Bovie Medical is trading in the green today, up 27.60% at $3.56. The medical product and device company saw its shares skyrocket after news of its newest device, J-Plasma. J-Plasma utilizes a gas ionization process producing a stable thin beam of ionized gas emitted from the J-Plasma hand piece that can be controlled in a wide range of temperatures and intensities, providing the surgeon great precision, minimal invasiveness and an absence of conductive currents during surgery. J-Plasma has continued to receive unparalleled support from influential surgeons across the country. Bovie Medical shares traded up near their 52-week high of $3.83.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.